Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

707 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The level of deletion 17p and bi-allelic inactivation of TP53 has a significant impact on clinical outcome in multiple myeloma.
Thanendrarajan S, Tian E, Qu P, Mathur P, Schinke C, van Rhee F, Zangari M, Rasche L, Weinhold N, Alapat D, Bellamy W, Ashby C, Mattox S, Epstein J, Yaccoby S, Barlogie B, Hoering A, Bauer M, Walker BA, Davies FE, Morgan GJ. Thanendrarajan S, et al. Among authors: morgan gj. Haematologica. 2017 Sep;102(9):e364-e367. doi: 10.3324/haematol.2017.168872. Epub 2017 May 26. Haematologica. 2017. PMID: 28550191 Free PMC article. No abstract available.
True spectrum of 14q32 translocations in multiple myeloma.
Pratt G, Fenton JA, Proffitt JA, Rawstron AC, Davies FE, Child JA, Morgan GJ. Pratt G, et al. Among authors: morgan gj. Br J Haematol. 1998 Dec;103(4):1209-10. doi: 10.1046/j.1365-2141.1998.1161d.x. Br J Haematol. 1998. PMID: 9886346 Free article. No abstract available.
Liposomal daunorubicin: in vitro and in vivo efficacy in multiple myeloma.
Pratt G, Wiles ME, Rawstron AC, Davies FE, Fenton JA, Proffitt JA, Child JA, Smith GM, Morgan GJ. Pratt G, et al. Among authors: morgan gj. Hematol Oncol. 1998 Jun;16(2):47-55. doi: 10.1002/(sici)1099-1069(199806)16:2<47::aid-hon622>3.0.co;2-3. Hematol Oncol. 1998. PMID: 10065112
Controversies surrounding the clonogenic origin of multiple myeloma.
Davies FE, Rawstron AC, Owen RG, Morgan GJ. Davies FE, et al. Among authors: morgan gj. Br J Haematol. 2000 Jul;110(1):240-1. doi: 10.1046/j.1365-2141.2000.02072-6.x. Br J Haematol. 2000. PMID: 10931011 Free article. No abstract available.
Minimal residual disease monitoring in multiple myeloma.
Davies FE, Rawstron AC, Owen RG, Morgan GJ. Davies FE, et al. Among authors: morgan gj. Best Pract Res Clin Haematol. 2002 Mar;15(1):197-222. doi: 10.1053/beha.2002.0192. Best Pract Res Clin Haematol. 2002. PMID: 11987924 Review.
Myeloma aetiology and epidemiology.
Morgan GJ, Davies FE, Linet M. Morgan GJ, et al. Biomed Pharmacother. 2002 Jul;56(5):223-34. doi: 10.1016/s0753-3322(02)00194-4. Biomed Pharmacother. 2002. PMID: 12199621 Review.
707 results